| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
1 |